Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial

Autor:	Rezvani, Hamid, Mortazavizadeh, Seyed Mohammadreza, Allahyari, Abolghasem, Nekuee, Amirabbas, Najafi, Safa Najjar, Vahidfar, Mohammadreza, Ghadyani, Mojtaba, Khosravi, Adnan, Qarib, Siroos, Sadeghi, Alireza, Esfandbod, Mohsen, Rajaeinejad, Mohsen, Rezvani, Alireza, Hajiqolami, Ali, Payandeh, Mehrdad, Shazad, Babak, Anjidani, Nassim, Meskinimood, Shahab, Alikhasi, Afsaneh, Karbalaeian, Moein, Salari, Sina
Zdroj:	In Clinical Therapeutics May 2020 42(5):848-859
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect